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A B S T R A C T   
The emergence of infectious agents with pandemic potential present scientific challenges from detection to data 
interpretation to understanding determinants of risk and forecasts. Mathematical models could play an essential 
role in how we prepare for future emergent pathogens. Here, we describe core directions for expansion of the 
existing tools and knowledge base, including: using mathematical models to identify critical directions and paths 
for strengthening data collection to detect and respond to outbreaks of novel pathogens; expanding basic theory 
to identify infectious agents and contexts that present the greatest risks, over both the short and longer term; by 
strengthening estimation tools that make the most use of the likely range and uncertainties in existing data; and 
by ensuring modelling applications are carefully communicated and developed within diverse and equitable 
collaborations for increased public health benefit.   
1. Introduction 
In 2020, the emergence of novel pathogens, or the successful spread 
of a pathogen into a new host environment, sprung to unwanted 
prominence. The previously unknown coronavirus, SARS-CoV-2 made 
the jump to humans from a zoonotic reservoir in China, and it rapidly 
achieved global reach (Kissler et al., 2020). Mathematical models were 
deployed at every stage of this trajectory and continue to be an impor-
tant part of scientific and political conversations regarding how to best 
contain the spread of SARS-CoV-2 and other pathogens with pandemic 
potential. But with the zoonotic virome diverse and rich with both 
known and unknown pathogens, key challenges remain to effectively 
use models to understand and mitigate the emergence of future zoonotic 
epidemics. Although there have been striking advances in some of the 
challenges laid out in previous overviews (Lloyd-Smith et al., 2015), for 
example in viral genomic epidemiology (Grubaugh et al., 2019) and 
characterising host competence (Mollentze et al., 2020), other chal-
lenges remain relatively neglected, such as understanding the potential 
roles of intermediate hosts in pathogen emergence (a role further 
complicated in the case of SARS-CoV-2 by the prospect of “spillback” 
from people into intermediate hosts) (Fagre et al., 2021). Still further 
challenges, such as characterising the nature and distribution of spill-
over risks and developing mechanistic cross-species models, have been 
topics of sustained inquiry but remain areas of active debate (Becker 
et al., 2019). In addition to these familiar challenges in mathematical 
modeling for pathogen emergence, new ones have emerged in the wake 
of SARS-CoV-2. Here we provide an overview of some of the current 
landscape of major challenges. 
For a pathogen to emerge within a new host population two steps are 
involved: introduction and establishment. Although these two steps can 
be further divided into ecologically distinct substeps (Plowright et al., 
2017), these two stages are crucially driven by distinct underlying dy-
namic processes. First, the infectious agent must be introduced into the 
new host population. In the case of zoonotic pathogens, which have been 
estimated to represent the majority (approximately 60%) of human 
pathogens (Jones et al., 2008), introduction into people (i.e., spillover) 
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may occur directly from a wildlife reservoir, from a livestock reservoir, 
or from a wildlife reservoir via an intermediate species such as a 
domesticated animal. The complex phenomenon of pathogen spillover 
occurs at the interface of people, animals, and environments and can be 
driven by changes in any of these realms, including human-wildlife 
contact patterns, climate and habitat composition, and human health 
and well-being. Introduction can also happen via movement of infected 
conspecifics from another population or via shifts in range caused by 
pathogenic evolution or environmental change (e.g., in the case of 
vector-borne pathogens, such as dengue, or those with an environmental 
reservoir, such as cholera). Second, the pathogen must become estab-
lished within the new host population (requiring sustained local trans-
mission between hosts, commonly summarised by a value of R0, or the 
expected number of secondary infections per infected individual, greater 
than 1). While these two stages of emergence are dynamically distinct 
phenomena, in the practice of modelling the two become intertwined, 
with data from each stage commonly necessary to make inferences about 
the other. Models are useful for advancing understanding of both stages 
as well as the interactions between them, and critical challenges remain 
to effectively modelling both stages. 
Here, we consider challenges in the ways in which models can 
contribute to strengthening data collection in the context of future 
pandemics; identify major challenges in predicting the emergence po-
tential of novel and potentially zoonotic pathogens; detail important 
questions in estimation of critical pandemic related parameters; and 
discuss challenges related to the use of models to inform public health 
response to disease emergence events. While the emergence of a novel 
pathogen might occur with devastating impact in any host species 
(evidenced, for example, by devastation of the citrus industry by the 
virus Citrus tristeza (Lee et al., 1994)), our focus is predominantly on 
emergence of pathogens within human populations. 
2. Data challenges of detecting emergence of future pandemics 
Two of the major questions around data in the context of future 
pandemics are: What data need to be collected to detect pathogen 
emergence? And, what can we do with (and what are the limits of) data 
that already exist? Models may contribute to answering both questions. 
Focusing on the first question, what surveillance tools could most 
effectively be leveraged to detect that pathogen emergence is (or was) 
occurring? Models could be used to probe what scope (temporal, 
spatial), types of data (individual measurements, clinical convenience 
samples, designed cohort studies), and types of measurements (symp-
toms, antibody responses, sequencing), and samping intensity are 
needed to reliably detect anomalies indicative of a pathogen emergence 
event. For example, a sudden uptick in cross-reactive antibodies to 
coronaviruses relative to baseline in a convenience sample (e.g., from a 
blood bank) might have provided a useful early warning of an emergent 
coronavirus (Mina et al., 2020), but the scale and scope of sampling 
required for a relevant anomaly to be reliably detected remains an open 
question, especially in light of recent evidence for cross-reactivity 
against SARS-CoV-2 in pre-pandemic sera in Southern Sudan, for 
example (Wiens et al., 2021). Similarly, genetic sequencing clearly has 
the potential to identify pathogen emergence events, via sampling in 
human populations, or in animal reservoirs. However, whether the 
required frequency of sampling, or range of reservoir or spillover host 
individuals sampled, is likely to be tractable is unknown, and should not 
be oversold (Carlson, 2020). Models could be designed to explore this 
issue, for example exploring the degree to which pathogen life histories 
might require different sampling designs, or whether existing conve-
nience samples (e.g., blood banks) or unexpected clusters of large case 
reports might be adequate. 
For pathogens that are already circulating within a focal population, 
emergence could take the form of the appearance and establishment of 
novel variants (e.g., greater transmission, or immune escape, or greater 
virulence, as for SARS-CoV-2 (McCormick et al., 2021); or features such 
as artemisinin resistance for malaria (Miotto et al. 2013)). Curtailing the 
spread of such variants has clear public health benefits. Characterising 
the degree of surveillance required to detect novel sequences at a fast 
enough rate to enable containment could be addressed via modeling. For 
example, detection of a potentially problematic novel sequence, and 
thus the full pipeline from sampling to analysis must occur at speeds and 
scope such that the emergent pathogen has not had a sufficient window 
of time to spread widely in the population, and will thus require models 
that encompass both the logistics of detection but also the life history of 
the pathogen, and magnitude of human connectivity. For poorly char-
acterised or unknown pathogens, predicting potential geographical 
‘emergence hotspots’ could facilitate more efficient and targeted sur-
veillance and model building (Lessler et al., 2017). Overall, a first 
challenge for models in addressing the data around emergence events is 
thus in informing the utility and best designs for curation of wide-scale, 
regularly collected data on pathogen (or variant) presence via direct 
detection or immune measurement. 
Moving to the question of the uses and limitations of existing path-
ogen emergence data, a major set of issues is the variation in data quality 
and completeness that emerges from global resource inequalities. Ebola 
outbreaks, for example, can easily evade detection in places where ac-
cess to care or availability of confirmatory diagnostics are limited 
(Jephcott et al., 2017; Glennon et al., 2019). Data on emerging out-
breaks inherently reflect those outbreaks which have successfully been 
detected and pathogens conclusively identified. Available data therefore 
reflects extensive but difficult-to-quantify biases toward larger, more 
syndromically distinct outbreaks in places with well-resourced health 
systems and effective disease surveillance programs (Glennon et al., 
2020). Furthermore, as much pathogen prevalence data is collected in 
clinical settings, surveillance represents a low priority relative to 
providing direct care in many situations (Kim et al., 2013). Models that 
characterise relevant data biases and feedback loops, as well as models 
that identify approaches to correct or account for such challenges, will 
be of value for planning exercises. Awareness of these limitations will be 
key to effective and just prioritisation of disease prediction and pre-
vention efforts. A second challenge for modeling is therefore in appro-
priately addressing these imbalances in the data, e.g., via integration of 
data collected by different systems (including qualitative study), ethical 
collaboration with diverse public health practitioners and other experts, 
and quantitative estimation of underreporting and other observation 
biases. 
Relatedly, beyond direct or indirect measures of pathogen presence 
and abundance, modeling might also be used to ask the question of 
whether existing non-traditional data-streams (such as contact patterns 
from mobile devices (Chang et al., 2021; Wesolowski et al., 2016), 
global connectivity from integrated global data sources (Tatem et al., 
2006), population heterogeneity by integrating satellite images to 
census data (Worldpop, 2021), digital trend data) could contribute to 
anticipating the trajectory that will follow pathogen emergence. Sug-
gestive use cases exist. For example, mobility data from mobile devices 
contributed to understanding the early phases of spread (and effects of 
containment) of SARS-CoV-2 (Lai et al., 2020). However, such data do 
not directly measure transmission events, and, for example, only limited 
predictability could be obtained from mobile phone data for the spatial 
spread of a measles outbreak in Pakistan (Wesolowski et al., 2018). In 
the context of future pandemics, models could evaluate the character-
istics of data that would most powerfully refine inference into future 
pandemic trajectories (temporal scale? spatial scale? demographic fea-
tures?) to identify a critical set of extensions that could be requested of 
technology companies and should be included in data use agreements 
(bearing in mind ethical and privacy constraints). Navigating such 
questions of scale, building responsive relationships between those 
collecting and modelling data, and developing empirically-grounded 
models to build, test, and refine hypotheses are long-term challenges 
in infectious disease dynamics (Lessler et al., 2015) that require special 
consideration and creativity in the case of novel pathogens for which 
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direct detection and measurement are especially difficult. 
3. Challenges in predicting emergence potential of wildlife and 
novel zoonotic pathogens 
Promptly detecting pathogen emergence is clearly, in itself, ambi-
tious. An even more ambitious goal would be to identify pathogens 
within their zoonotic reservoir before they have had the opportunity to 
spill over into people, as well as to understand and mitigate the risk of 
emergence after spillover. There are many possible threads by which 
models could contribute to this. 
Sequencing important pathogen reservoirs, such as the ‘virome’ is 
increasingly tractable on large scales, and has certainly deepened our 
understanding of the community ecology of viruses (Wille et al., 2019). 
Nevertheless, vast numbers of species remain undescribed. Estimates of 
richness in the global zoonotic virome vary widely, from approximately 
10,000 viruses with zoonotic potential (Carlson et al., 2019) to over 600, 
000 (Carroll et al., 2018). As the vast majority of sequenced viruses will 
be irrelevant to human health, identifying ways to target sampling to 
more relevant parts of the biome is an important question, for viruses, 
but also beyond (bacteria, protozoa), and with potential to contribute to 
monitoring of zoonotic reservoirs (Lloyd-Smith et al., 2015). This 
question links to the important theoretical challenge of pinpointing 
characteristics of pathogens with spillover potential. 
A series of theoretical approaches have evaluated the degree to 
which very general characteristics (e.g., mutation rate, degree of clus-
tering in host contacts, pathogen related mortality) shape risks of 
pathogen emergence (reviewed in Gandon et al., 2013). Another way to 
tackle this question is to use a comparative approach: models are used to 
leverage knowledge and trait characteristics of hosts and pathogens that 
have historically spilled over to identify features of future pandemic 
pathogens (Olival et al., 2017; Wells et al., 2020; Shaw et al., 2020). 
Remaining key challenges in this area are to more realistically link 
species-level predictions to real-world landscapes by accounting for 
fine-scale species distributions and exposure risk. This area of study may 
prove particularly important for the interdisciplinary challenge of un-
derstanding the effects of ecological and climatic change on disease 
emergence. A related approach, and which echoes a perennial and 
persisting challenge in biology is in generating a genotype to phenotype 
map (Visscher et al., 2017). This might require possibly unfeasible (at 
this stage) mechanistic understanding of features from cellular tropism 
to pathogen replication to interactions with existing immunity in animal 
reservoirs and human populations. Such understanding would enable 
characterization of host range and zoonotic potential, but also the tra-
jectory of adaptation to human to human transmission that could occur 
subsequent to introduction of pathogens into human populations. Better 
calibrated and detailed models capturing within-host to between-host 
dynamics (Ke et al., n.d.) will be important to the latter. Further, 
arguably, a critical and as yet unresolved component will be a larger 
understanding of the landscape of immunity for the focal species and 
across the pathogen community (Rice et al., 2021), as cross-reactivity 
among different pathogen species might constrain pathogen emer-
gence (an effect that has been proposed, for example, for influenza; 
Gostic et al., 2016). Engaging with this in turn requires engaging with 
the important modeling challenge of moving beyond a single pathogen 
perspective to encompass multiple species, a well recognised and per-
sisting challenge in the study of infectious pathogens (Lipsitch et al., 
2009; Wikramaratna et al., 2015; Kucharski et al., 2016). 
As the focal pathogen spreads, growing immunity within the popu-
lation will elicit selection pressures on within-human replication and 
human to human transmission. For SARS-CoV-2, in early 2021, variants 
of concern feature plasticity in combinations of traits encompassing 
receptor avidity, immune escape, transmissibility and virulence (Martin 
et al., 2021). Knowledge of correlations between these traits and 
trade-offs (implying a genotype to phenotype map) would open the way 
to better anticipating everything from immune escape to shifts in 
virulence, as well as a better understanding of how these evolutionary 
events might be driven by acquired immunity, therapeutics, or vacci-
nation regimes (Saad-Roy et al., 2021). While the potential for such 
mechanistic details to refine the predictions of evolutionary models is 
clear, adequate characterisation of mechanism remains an important 
frontier, to which more nuanced knowledge of molecular mechanisms, 
through to better models of within-host spread could be brought to bear. 
An important component in developing models to project the im-
pacts of such pathogen traits and trade-offs (or the genotype to pheno-
type map) is that they may differ from host to host. Sex differences in 
immune function, for example, are ubiquitous (Klein and Katie, 2016); 
and older individuals generally have less efficient immunity as a result 
of immunosenescence (Simon et al., 2015). The feedback driven nature 
of immunity may also mean that very small differences may escalate into 
highly variable outcomes (e.g., along the lines described in ecological 
terms by ‘alternative stable states’ (Metcalf et al., 2020)). Such popu-
lation heterogeneities may have important consequences for both the 
prospects for pathogen spillover, initial pathogen spread (i.e., the 
effective reproductive number (Lloyd-Smith et al., 2005; Metcalf et al., 
2015a, 2015b)), and selection on pathogen traits, such as virulence 
(Miller and Metcalf, 2019). However, such heterogeneities remain 
relatively rarely modeled, in part as they are generally extremely hard to 
quantify in practice (see next section), especially when one considers 
that individual variation in important traits such as immunity, behavior, 
and mobility may all compound to produce highly complex patterns. 
Nevertheless, efforts to evaluate the purely theoretical impact of such 
heterogeneities, rooted in broadly known differences (by sex, age) could 
significantly advance understanding of variation in transmission dy-
namics and disease outcomes within and between host populations. 
4. Challenges in estimation around novel pathogen 
establishment and early-stage epidemics 
While many spillover events may rapidly go extinct in human pop-
ulations, sometimes primary infections (i.e., people infected directly 
from the reservoir or entering the local population from elsewhere) will 
go on to infect other people. Branching process models are commonly 
used to estimate the risk that initial cases of disease will establish sus-
tained chains of transmission (Althaus et al., 2015.; Guzzetta et al., 
2016; Abdullah et al., 2018; Thompson et al., 2016, 2019, 2020). These 
models were applied early in the COVID-19 pandemic, when cases had 
only been observed in China, to assess the risk the cases exported to 
other countries would establish local epidemics and to investigate how 
control measures affect this risk (Hellewell et al., 2020; Thompson, 
2020). Modeling approaches have also been developed to extract key 
epidemiological measures such as R0 from observations of early ‘stut-
tering chains’ of transmission (Blumberg and James, 2013). Although 
several methods have been developed to estimate R0 from such early 
observational data, these estimates are highly uncertain–especially for 
diseases characterised by high heterogeneity in secondary infection-
s–and can be misleading when generalised. Stuttering chains can be 
recurrent but not necessarily transition to a larger threat (as is the case 
for MERS-CoV, for example) or can appear subcritical in many settings 
while retaining epidemic potential (as in the case of Ebola). Further 
methods development is needed to help estimate (and contextualise 
estimates of) core parameters such as R0, the incubation period, and the 
asymptomatic ratio of a disease in the earliest and most epidemiologi-
cally uncertain phases of outbreaks. Furthermore, combining such 
methods with an understanding of local context is important for making 
early estimates more reliable, actionable, and generalisable. Working 
with public health authorities attuned to the particular circumstances of 
localised outbreaks as well as integrating novel epidemiological data 
with pre-existing, geographically varying data (e.g., mobility data, 
serological data to estimate potential cross-immunity) could help clarify 
uncertainty and generalisability when estimating risk of a novel path-
ogen establishing ongoing transmission. 
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For events that follow this phase, the classical modeling toolkit was 
perhaps first defined during the emergence of HIV (May and Anderson, 
1987). This work established a roadmap for estimating the range of core 
parameters required to delineate the trajectory that an emerging path-
ogen will take from the early growth in cases (R0, generation time, in-
cubation period, overdispersion, infection fatality ratio (Metcalf et al., 
2017)). This toolkit has been expanded by use of genetic data-streams to 
infer incidence or pathogen population growth (Vaughan et al., 2019), 
or innovative use of cross-sectional data on viral copy numbers across 
individual populations to capture whether pathogen populations are 
growing or shrinking (Hay et al., 2020). There are presumably an array 
of further innovations in this space that might further enhance this set of 
approaches; building around elements listed in previous sections, and 
grappling with key features such as how to address variability (e.g., 
presence of superspreading) but also uncertainty in critical transmission 
parameters (e.g., incubation time, quantities such as R0 in human pop-
ulations once spillover has occurred) and grounding them mechanisti-
cally (e.g., in heterogeneity in contact patterns or distributions of 
co-morbidities). 
Integrating diverse data sources is likely to prove important both in 
the very early phases when stuttering chains are occurring, and once 
sustained spread has occurred. For example, phylodynamic approaches 
can provide another window onto how a virus moves through space 
(Bedford et al., 2020; Deng et al., 2020). Such integration can also 
provide a means to triangulate on core measures such as R0 (Vaughan 
et al., 2020.) using a different source of data (noting that this approach 
may have limited power to resolve the issue of pinning down trans-
mission for a pathogen like SARS-CoV-2 where the genome evolves 
relatively slowly, time to onset of symptoms, as well as incubation and 
infection periods are variable, and the asymptomatic ratio is high). 
Expanding models to estimate critical aspects of within-host dynamics 
(using data on viral load, immune parameters, etc) but also to translate 
these estimates into parameters relevant to population scale trans-
mission remains very much in its early phases. 
There are also very important required modelling extensions of the 
classical toolkit to use new data sources. There is arguably more data 
than ever before on aspects of human contact and risk. Since every 
model of pathogen emergence arguably involves a contact rate, such 
data have clear potential. However, there are still gaps in thinking about 
how best to harness these data. Transmission events remain frustratingly 
unspecified; they are only ‘observed’ (and even then, indirectly) in 
extraordinarily detailed data such as those obtained by contact tracing 
(e.g., Bi et al. 2020)). Thus, we do not know whether the ‘medium’ or 
‘big’ data sources we have access to at the population scale, be they diary 
studies of contacts, or mobile phone call data records (Grantz et al., 
2020) actually capture transmission relevant contacts. Sampling bias in 
these and other less traditional datasets, from mobile phone records 
viral sequence data, is pervasive and difficult to assess systematically; 
such bias may lead to mis-specification when these samples are used to 
inform population-level models. A challenge is finding a principled way 
to grapple with these issues of model mis-specification that remains 
tractable, and also sensibly reflects uncertainty. Multi-model compari-
sons (Reich et al., 2019) may make important contributions here. 
Models of early pathogen spread that better account for logistics and 
health systems are relevant to understanding and adjusting for hetero-
geneous surveillance and reporting, but also to understanding and 
improving potential for intervention and containment at early phases. 
Spatial mechanistic models that include population connectivity net-
works, socioeconomic factors and distribution of potential reservoir 
species as recently employed to model Ebola emergence (Redding et al., 
2019) may provide crucial insights into spatial aspects of disease 
emergence. Such mechanistic models can be also used to explore a wide 
range of possible scenarios in order to explore the model behaviour 
across a large array of combinations of transmission parameters or 
narrow down intractable parameter values through likelihood-free 
approximation methods such as Approximate Bayesian Computation 
(Minter and Retkute, 2019, Wells et al., 2019). Such likelihood-free 
methods rely on narrowing down unknown parameters by matching 
the output of computer simulations to available empirical evidence and 
may be also used as means for generating forecasts or evaluating the 
outcomes of a range of possible scenarios of how epidemics may unfold 
after the initial emergence process. They may therefore prove useful for 
addressing the technical challenges of multi-scale models. Challenges to 
be tackled in this area—in which models integrate many layers and 
scales to account for realistic social-spatial aspects of disease—include 
balancing inclusion of these critical aspects with sensible model 
complexity, efficient sampling of large unknown parameter spaces, 
integrating social and systemic information appropriately (e.g., 
grounding modelled relationships in social scientific theories of disease), 
and accurately validating models (Oberpriller et al., 2021) amid the 
generally sparse empirical evidence available for emerging diseases. 
Many of these challenges are common across multi-scale modelling 
approaches (Gog et al., 2015), but are additionally complicated by the 
unique data limitations and complex social aspects of disease 
emergence. 
5. Challenges in harnessing models for public health benefit 
Beyond developing methods and theory, there are important chal-
lenges in implementing models to effectively contribute to outbreak 
prevention and response. Such challenges are cross-cutting, affecting 
every stage and scale of emergence and of model development. Broadly, 
these challenges include assessment and communication of uncertainty; 
clear contextualisation of short- and long-term disease prevention and 
control strategies; development of infrastructure for effective and 
responsive modelling in cooperation with public health bodies; and 
equitable access to epidemiological tools and insights provided by 
modelling. 
Effectively assessing and communicating the uncertainty involved in 
model predictions is crucial to meeting the needs of public health de-
cision makers and policy makers, as well as facilitating informed 
decision-making by the general public in the face of misinformation 
(Metcalf et al., 2015a, 2015b). Clear communication is especially diffi-
cult in the early stages of an epidemic, when basic data such as infection 
rates, infection fatality ratios, and risk factors may be unavailable or 
strongly skewed by the chance circumstances of early cases. While this 
difficulty is common across most disease emergence events including 
evolution and range expansion of known human pathogens, it is espe-
cially critical in the case of novel pathogens, for which the most basic 
physiological and epidemiological aspects of disease are typically un-
known at the point of initial case detection. Strong observation biases 
common in early outbreak data (shaped, for example, by inequities in 
access to diagnostic testing) further limit the efficacy and accuracy of 
modelling in early-stage epidemics. Limitations of data and modelling 
tools are especially salient in attempts to forecast the absolute course of 
an epidemic (e.g., as opposed to modelling relative impacts of in-
terventions); forecasts are subject to the same pervasive limitations as 
other models, as well as inevitable feedback loops between model pro-
duction, public health decision-making, individual risk perceptions and 
tolerances, and the impacts of behavioural and political choices (Funk 
et al., 2015). Careless or overconfident communication of modelling 
predictions during this stage risks losing the trust and cooperation of 
public health decision makers and the general public (Kupferschmidt, 
2020). Nonetheless, the early stages of an outbreak, while case counts 
are still low, offer the best opportunity for effective intervention to 
minimise direct and indirect costs. Waiting for more accurate data risks 
foregoing the chance to intervene while an outbreak is still manageable. 
There is therefore an urgent need to develop strategies to balance 
communication of urgency and uncertainty in presenting modelling 
results as a disease begins to emerge, as well as to effectively commu-
nicate changes in strategy as modelling approaches evolve with new 
data (Becker et al., 2021). 
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Similarly, there is an urgent need to improve communication of 
model assumptions and limitations, including contextualisation of short- 
term and narrowly disease-centered strategies (e.g., vaccination and 
behavior changes such as masking and social distancing) within local 
context and long-term or holistic strategies (e.g., broad improvements in 
sanitation, access to safe housing and work environments, and univer-
salisation of care). Models have been used to disentangle the influences 
of such factors on the dynamics of endemic and historical emerging 
diseases (e.g., Phillips et al., 2020), and recent efforts have retrospec-
tively estimated the consequences of such fundamental causes of disease 
as structural racism on the emergence of COVID-19 in the United States 
(Richardson et al., 2021). Prospectively estimating the impacts of 
strengthened health infrastructure, public health policies of critical but 
indirect benefit for transmission (e.g., eviction moratoria and decar-
ceration), and broad social change, however, represents a major chal-
lenge. As modellers work to advance our understanding of the ecological 
and social environment (e.g., climate, health infrastructure, structural 
inequality, and interactions with other diseases) on disease spread, it 
remains important to highlight the limitations of acting only on the 
proximate mechanisms and easily measured parameters most commonly 
captured by quantitative modelling. In particular, modellers can support 
systemic public health efforts by emphasising that parameters such as R0 
and infection fatality ratios are emergent and changeable properties of a 
disease within a human social context, rather than inherent properties of 
pathogens themselves. Relatedly, heterogeneities in such values are not 
fully biological or neutral, but often reflect social and political injustices 
that modellers should not be afraid to identify as causes of disease or 
targets for intervention (Bhala et al., 2020). 
Finally, additional efforts are needed to define and shape the role of 
modelling within broader public health efforts in disease prevention and 
outbreak response. More work is needed to strengthen collaborations 
between modellers, public health decision makers, and the public. 
Support is also needed for data sharing infrastructure and for the 
development of accessible tools based on modelling to enable insights 
from modelling to be distributed more equitably. In response to COVID- 
19, national and international authorities have committed to new 
modelling-focused public health centres such as the US Center for 
Forecasting and Outbreak Analytics and the new WHO Hub for 
Pandemic and Epidemic Intelligence (Centers for Disease Control and 
Prevention, 2021, Balakrishnan and Shankar, 2021). Such bodies aim to 
address clear needs regarding international coordination and data 
sharing, but it remains to be seen whether they will further isolate and 
privilege quantitative knowledge (contributing to the epistemic injustice 
that pervades global health; Bhakuni et al., 2021) or be able to make 
room for the truly diverse collaboration needed to address the complex, 
global, interdisciplinary challenge of disease emergence. Aligning in-
centives away from profit-driven and nationalist solutions (Katz et al., 
2021) as well as academic reward systems that prioritise novelty (Met-
calf et al., 2015a, 2015b), and instead building networks of global, 
equitable, diverse, and transparent collaboration is one of the central 
challenges of pandemic prevention and one in which modellers ought to 
be active participants. 
6. Conclusions 
Detection, and even more ambitiously, anticipation of the emergence 
of an infectious agent into a new host population could importantly 
contribute to efforts to assess, prevent, control, and contain future 
pandemic risks. We have outlined here an array of ways that models 
have the potential to inform these questions, and important challenges 
ahead. A global health perspective underscores the enormous advan-
tages in terms of speed and transparency for early reporting of poten-
tially important spillover events. Both better fundamental 
understanding and expectations, alongside global data standards, 
transparency and sharing, informed by model framing, could contribute 
to this while also guarding against over-selling the potential of this 
research agenda. 
Acknowledgements 
The authors would like to thank the Isaac Newton Institute for 
Mathematical Sciences, Cambridge, for support during the Infectious 
Dynamics of Pandemics programme where work on this paper was un-
dertaken. This work was supported by EPSRC grant no. EP/R014604/1. 
MB was funded by NWO Rubicon (019.192EN.017). IFM was funded by 
the High Meadows Environmental Institute, Princeton. EEG is funded by 
a Sir Henry Wellcome Postdoctoral Fellowship [220463/Z/20/Z]. We 
would like to thank Denis Mollison, Valerie Isham, Hans Heesterbeek, 
and anonymous reviewers for their helpful comments on earlier drafts. 
References 
Abdullah, N., Kelly, J.T., Graham, S.C., Birch, J., Gonçalves-Carneiro, D., Mitchell, T., R. 
N, Lythgoe, K.A., Logan, N., Hosie, M.J., Bavro, V.N., Willett, B.J., Heaton, M.P., 
Bailey, Thompson, 2018. Structure-guided identification of a nonhuman 
morbillivirus with zoonotic potential. J. Virol. 92 (23) e01248-18.  
Althaus, Christian L., Gsteiger, Sandro, Musa, Emmanuel O., Shuaib, Faisal, Low, Nicola, 
2015. Ebola virus disease outbreak in nigeria: transmission dynamics and rapid 
control. Epidemics 11, 80–84. 
Balakrishnan, Shankar, Vijay, 2021. WHO-Germany collaboration for pandemic 
intelligence research. Lancet Microbe 2 (7), E290. 
Becker, Alexander, D., Kyra, H.Grantz, Sonia T, Hegde, Sophie, B.érubé, 
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